Disease Activity is Associated with Depression and Anxiety in Cushing's Syndrome During COVID-19 Pandemic

Piskinpasa, Hamide; Turgut, Seda; KARAARSLAN, Özlem; Bozkur, Evin; Esen, Ayşe Didem; PAMUK, Naim; ÇAKIR, İlkay; Mert, Meral; DOĞANŞEN, Sema ÇİFTÇİ

doi:10.25179/tjem.2021-82526

Cited by 2 publications

(2 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The frequency and severity of COVID-19 infection have been associated both with glycemic status and obesity in many studies [2][3][4]. Investigations analyzing the association of other endocrine disorders also, affecting gonads, thyroid or adrenal glands, have been conducted so far [5][6][7][8]. Various associations of COVID-19 infection with the thyroid gland, such as subacute granulomatous thyroiditis (SAT) or Graves' disease, have been reported during the pandemic [7,9,10].…”

Section: Introductionmentioning

confidence: 99%

Differences in Clinical Aspects Between Subacute Thyroiditis Associated with COVID-19 Vaccines and Classical Subacute Thyroiditis

et al. 2022

View full text Add to dashboard Cite

Subacute thyroiditis(SAT) developed after SARS-CoV-2 vaccines has been less studied. We aimed to compare classical SAT and SAT developed after SARS-CoV-2 vaccines in the context of clinical aspects. Adults with SAT detected in 90 days of COVID-19 vaccination (CoronaVac® or Pfizer/BioNTech®) were grouped as Vac-SAT (CoronaVac-SAT and BioNTech-SAT). Those with a history of SARS-CoV-2 or upper respiratory tract infection in 6 months before the vaccination, or vaccination with another antiviral vaccine after COVID-19 vaccination were excluded. Those with SAT detected before COVID-19 pandemic were grouped as Classical-SAT. Of total(n=85), female/male(54/31) ratio and age(43(23-65)) were similar in Vac-SAT(n=23) and Classical-SAT(n=62) groups. Duration between vaccine and SAT was 45(7-90) days, and similar in CoronaVac-SAT(n=5) and BioNTech-SAT(n=18) groups. SAT-duration was 28(10-150) days, and higher in Vac-SAT than in Classical-SAT group(p=0.023). SAT was developed after the 1st dose vaccine in minority in CoronaVac-SAT(n=2) and BioNTech-SAT(n=3) groups(p=0.263). Previous LT4 use, and TSH elevation after resolution were more frequent in Vac-SAT than in Classical-SAT(p=0.027 and p=0.041, respectively). We included a considerable number of patients with SAT occurred after COVID-19 vaccines. We cannot provide clear evidence regarding the association of COVID-19 vaccines with SAT. SAT associated with CoronaVac® or BioNTech® seems unlikely to be occurred after the 1st dose, and to have a longer duration, more likely to be associated with previous LT4 use and lead TSH elevation after resolution than Classical-SAT. TSH should be followed-up after the resolution of SAT detected after COVID-19 vaccination.

show abstract

Section: Introductionmentioning

confidence: 99%

Differences in Clinical Aspects Between Subacute Thyroiditis Associated with COVID-19 Vaccines and Classical Subacute Thyroiditis

et al. 2022

View full text Add to dashboard Cite

show abstract

“…COVID-19 pandemic and social isolation can affect mental health parameters in patients with diabetes mellitus [3]. Psychological distress can increase depressive symptoms in endocrinological comorbid diseases and cause the negative consequences of diabetes mellitus [4][5][6]. Fear of getting coronavirus infection and running out of diabetes medications, the inability to manage hypoglycemia or hyperglycemia, the fear of not reaching the doctor, the decrease in social support from family and friends due to quarantine caused high anxiety and depression symptoms among diabetic patients [2,7].…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c

Bahadır¹,

Erdoğan²

2022

Acta Medica

View full text Add to dashboard Cite

Objective: To determine the severity of fear and anxiety of COVID-19 in diabetic patients and to evaluate their relationship with HbA1c. Materials and methods: Between December 2020 and March 2021, a total of 249 patients were included in the study. Demographic characteristics, duration of diabetes, glycosylated hemoglobin A1c (HbA1c) values of the patients were recorded. Fear and anxiety related to COVID-19 were evaluated with the validated Turkish version of the Fear of COVID Scale (FCS) and Coronavirus Anxiety Scale (CAS). FCS and CAS were compared between the diabetic group and the control group. The relationship between FCS and CAS and HbA1c, diabetes year, age, gender, educational status, place of residence, and employment status was investigated. Results: Median level of HbA1c and duration of diabetes mellitus were 7.65% (range 5.4-13.6) and 10 years (range 1-32) respectively. FCS was higher in the diabetic group compared to the control group (p=0.025). There was no significant difference between the diabetic and control groups regarding CAS. There was no relationship between HbA1c and FCS and CAS (p=0.919, r=0.008, p=0.725, r=0.027, respectively). Anxiety was higher in females than males in diabetic groups (p=0.009). Conclusions: The fear of COVID-19 is higher in diabetic patients compared to the general population. There was no relationship between fear and anxiety of COVID-19 and HbA1c. However, to protect long-term mental health, there should be strategies to detect and reduce the anxiety and fear caused by the pandemic in the services for diabetic patients.

show abstract

Disease Activity is Associated with Depression and Anxiety in Cushing's Syndrome During COVID-19 Pandemic

Cited by 2 publications

References 34 publications

Differences in Clinical Aspects Between Subacute Thyroiditis Associated with COVID-19 Vaccines and Classical Subacute Thyroiditis

Differences in Clinical Aspects Between Subacute Thyroiditis Associated with COVID-19 Vaccines and Classical Subacute Thyroiditis

COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c

Contact Info

Product

Resources

About